Healthcare provider profile · identity verified

Marian Doe, MD

Family Practice · FRESNO, CA · NPI 1861640997

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Quetiapine Fumarate	Quetiapine Fumarate	599	75
Levothyroxine Sodium	Levothyroxine Sodium	529	75
Furosemide	Furosemide	426	69
Atorvastatin Calcium	Atorvastatin Calcium	419	66
Donepezil Hcl	Donepezil Hcl	261	38
Amlodipine Besylate	Amlodipine Besylate	256	33
Pantoprazole Sodium	Pantoprazole Sodium	225	30
Gabapentin	Gabapentin	214	34
Spironolactone	Spironolactone	209	28
Sertraline Hcl	Sertraline Hcl	204	24
Eliquis	Apixaban	182	26
Metoprolol Succinate	Metoprolol Succinate	182	24
Lisinopril	Lisinopril	177	25
Losartan Potassium	Losartan Potassium	169	23
Omeprazole	Omeprazole	158	27
Lorazepam	Lorazepam	156	39
Memantine Hcl	Memantine Hcl	155	20
Escitalopram Oxalate	Escitalopram Oxalate	154	20
Potassium Chloride	Potassium Chloride	151	20
Trazodone Hcl	Trazodone Hcl	141	20
Carvedilol	Carvedilol	127	16
Mirtazapine	Mirtazapine	117	17
Tamsulosin Hcl	Tamsulosin Hcl	115	21
Metformin Hcl	Metformin Hcl	108	15
Montelukast Sodium	Montelukast Sodium	93	13
Rosuvastatin Calcium	Rosuvastatin Calcium	93	13
Citalopram Hbr	Citalopram Hydrobromide	91	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	91	24
Simvastatin	Simvastatin	87	12
Tramadol Hcl	Tramadol Hcl	80	15
Buspirone Hcl	Buspirone Hcl	78	15
Alendronate Sodium	Alendronate Sodium	71	suppressed
Januvia	Sitagliptin Phosphate	70	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	68	suppressed
Xarelto	Rivaroxaban	67	suppressed
Temazepam	Temazepam	65	suppressed
Atenolol	Atenolol	64	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	64	32
Cephalexin	Cephalexin	62	47
Lovastatin	Lovastatin	62	suppressed
Jardiance	Empagliflozin	57	suppressed
Levetiracetam	Levetiracetam	57	suppressed
Clopidogrel	Clopidogrel Bisulfate	56	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	15
Enalapril Maleate	Enalapril Maleate	50	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	50	suppressed
Duloxetine Hcl	Duloxetine Hcl	49	12
Famotidine	Famotidine	45	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	44	suppressed
Memantine Hcl Er	Memantine Hcl	42	suppressed
Alprazolam	Alprazolam	41	suppressed
Ezetimibe	Ezetimibe	41	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	40	suppressed
Bupropion Xl	Bupropion Hcl	39	suppressed
Celecoxib	Celecoxib	39	suppressed
Divalproex Sodium	Divalproex Sodium	38	suppressed
Amiodarone Hcl	Amiodarone Hcl	37	suppressed
Nystatin	Nystatin	37	19
Glipizide	Glipizide	35	suppressed
Digoxin	Digoxin	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	33	14
Midodrine Hcl	Midodrine Hcl	33	suppressed
Lactulose	Lactulose	31	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	30	suppressed
Finasteride	Finasteride	28	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Azithromycin	Azithromycin	26	20
Latanoprost	Latanoprost	26	suppressed
Pregabalin	Pregabalin	26	suppressed
Telmisartan	Telmisartan	26	suppressed
Breo Ellipta	Fluticasone/Vilanterol	25	suppressed
Baclofen	Baclofen	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	24	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	23	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	22	suppressed
Olanzapine	Olanzapine	21	suppressed
Prednisone	Prednisone	21	18
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Meclizine Hcl	Meclizine Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Bumetanide	Bumetanide	19	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Ibuprofen	Ibuprofen	19	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Naproxen	Naproxen	19	suppressed
Ondansetron Hcl	Ondansetron Hcl	19	12
Valacyclovir	Valacyclovir Hcl	18	suppressed
Valsartan	Valsartan	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Belsomra	Suvorexant	17	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	17	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	16
Diclofenac Sodium	Diclofenac Sodium	16	suppressed
Fluconazole	Fluconazole	16	13
Loperamide	Loperamide Hcl	16	suppressed
Paroxetine Hcl	Paroxetine Hcl	16	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	16	16
Bisoprolol Fumarate	Bisoprolol Fumarate	15	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	15	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	15	12
Gemtesa	Vibegron	15	suppressed
Risperidone	Risperidone	15	suppressed
Rytary	Carbidopa/Levodopa	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	14	suppressed
Febuxostat	Febuxostat	14	suppressed
Folic Acid	Folic Acid	14	suppressed
Glimepiride	Glimepiride	14	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	13	suppressed
Fenofibrate	Fenofibrate,micronized	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Horizant	Gabapentin Enacarbil	13	suppressed
Metformin Hcl Er	Metformin Hcl	13	suppressed
Mresvia	Rsv Vaccine, Pref, Mrna/Pf	13	13
Ramelteon	Ramelteon	13	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Benazepril-Hydrochlorothiazide	Benazepril/Hydrochlorothiazide	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Estradiol	Estradiol	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	12	suppressed
Insulin Degludec Pen (U-100)	Insulin Degludec	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Bethanechol Chloride	Bethanechol Chloride	11	suppressed
Fluticasone Propionate	Fluticasone Propionate	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Nifedipine Er	Nifedipine	11	suppressed
Nystop	Nystatin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error